ProfileGDS4718 / 210593_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 45% 36% 42% 40% 35% 42% 40% 45% 42% 44% 40% 42% 34% 37% 39% 39% 43% 40% 50% 38% 39% 47% 39% 33% 39% 39% 25% 39% 41% 34% 39% 40% 45% 30% 37% 38% 39% 42% 38% 40% 32% 33% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1053342
GSM549102patient 115, normal, homogenized [OPG study]5.2835845
GSM549104patient 119, normal, homogenized [OPG study]4.7870636
GSM549108patient 138, normal, homogenized [OPG study]5.1708542
GSM549119patient 077, normal, homogenized [OPG study]4.9908140
GSM549133patient 032, cancer, homogenized [OPG study]4.6945235
GSM549139patient 042, cancer, homogenized [OPG study]5.0535442
GSM549099patient 107, normal, homogenized [OPG study]4.9994440
GSM549109patient 139, normal, homogenized [OPG study]5.2912345
GSM549110patient 046, normal, homogenized [OPG study]5.0903842
GSM549114patient 063, normal, homogenized [OPG study]5.1354244
GSM549122patient 082, normal, homogenized [OPG study]4.9888340
GSM549134patient 033, cancer, homogenized [OPG study]5.0981642
GSM549136patient 036, cancer, homogenized [OPG study]4.6347834
GSM549140patient 044, cancer, homogenized [OPG study]4.785237
GSM549111patient 047, normal, homogenized [OPG study]4.9277239
GSM549113patient 057, normal, homogenized [OPG study]4.8828539
GSM549132patient 031, cancer, homogenized [OPG study]5.1046943
GSM549137patient 038, cancer, homogenized [OPG study]4.9656840
GSM549142patient 047, cancer, homogenized [OPG study]5.6653350
GSM549100patient 110, normal, homogenized [OPG study]4.932438
GSM549107patient 135, normal, homogenized [OPG study]4.9197639
GSM549115patient 068, normal, homogenized [OPG study]5.2638547
GSM549116patient 072, normal, homogenized [OPG study]4.9259339
GSM549120patient 078, normal, homogenized [OPG study]4.6820633
GSM549131patient 030, cancer, homogenized [OPG study]4.887139
GSM549118patient 074, normal, homogenized [OPG study]4.959739
GSM549129patient 027, cancer, homogenized [OPG study]4.3716625
GSM549123patient 088, normal, homogenized [OPG study]4.91939
GSM549124patient 006, cancer, homogenized [OPG study]5.098241
GSM549126patient 015, cancer, homogenized [OPG study]4.6867334
GSM549128patient 025, cancer, homogenized [OPG study]4.9106139
GSM549103patient 117, normal, homogenized [OPG study]5.0625240
GSM549117patient 073, normal, homogenized [OPG study]5.1789945
GSM549138patient 041, cancer, homogenized [OPG study]4.5385930
GSM549141patient 045, cancer, homogenized [OPG study]4.7852437
GSM549130patient 028, cancer, homogenized [OPG study]4.8810738
GSM549101patient 111, normal, homogenized [OPG study]4.9869339
GSM549105patient 128, normal, homogenized [OPG study]5.0881842
GSM549106patient 134, normal, homogenized [OPG study]4.8320138
GSM549112patient 048, normal, homogenized [OPG study]4.9879440
GSM549125patient 011, cancer, homogenized [OPG study]4.6356932
GSM549127patient 024, cancer, homogenized [OPG study]4.6793233
GSM549135patient 035, cancer, homogenized [OPG study]4.6166333